PRC Clinical Supports Regenerative Medicine Research
PRC Clinical, a CRO specializing in clinical trial management, is joining the Alliance for Regenerative Medicine (ARM).
PRC Clinical, a CRO specializing in clinical trial management, is joining the Alliance for Regenerative Medicine (ARM). PRC Clinical has expertise in stem cell and regenerative research working with sponsors in the United States and Israel. Regenerative Medicine is focused on the development and application of cell-based therapies and related technologies to enhance the natural healing process, and/or replace or regenerate organs and tissues. ARM members include Pfizer, Johnson & Johnson and Novartis.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
